| pubmed-article:9165133 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9165133 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:9165133 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:9165133 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
| pubmed-article:9165133 | lifeskim:mentions | umls-concept:C0460004 | lld:lifeskim |
| pubmed-article:9165133 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:9165133 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:9165133 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:9165133 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:9165133 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:9165133 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9165133 | pubmed:dateCreated | 1997-7-10 | lld:pubmed |
| pubmed-article:9165133 | pubmed:abstractText | In 1986 a prospective, randomized, multi-centre trial for evaluation of neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in the treatment of advanced squamous cell carcinoma of the head and neck was initiated. As survival in this group of patients is poor the purpose was to find a possible survival benefit of the chemotherapy in addition to radiotherapy compared to radiotherapy only. | lld:pubmed |
| pubmed-article:9165133 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9165133 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9165133 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9165133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9165133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9165133 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9165133 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9165133 | pubmed:issn | 0167-8140 | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:BiörklundAA | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:AnderssonTT | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:HansenH SHS | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:LewisMM | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:BerthelsenAA | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:OvergaardMM | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:MerckeCC | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:RingborgUU | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:HansenOO | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:RosengrenBB | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:DamberLL | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:JonssonHH | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:ModigHH | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:TausjöJJ | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:EvensenJ FJF | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:JetlundOO | lld:pubmed |
| pubmed-article:9165133 | pubmed:author | pubmed-author:BlomqvistEE | lld:pubmed |
| pubmed-article:9165133 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9165133 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:9165133 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9165133 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9165133 | pubmed:pagination | 23-8 | lld:pubmed |
| pubmed-article:9165133 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:meshHeading | pubmed-meshheading:9165133-... | lld:pubmed |
| pubmed-article:9165133 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9165133 | pubmed:articleTitle | Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study. | lld:pubmed |
| pubmed-article:9165133 | pubmed:affiliation | Department of Oncology, Huddinge University Hospital, Sweden. | lld:pubmed |
| pubmed-article:9165133 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9165133 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9165133 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9165133 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9165133 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:9165133 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
